New inhaler combo aims to improve heart and lung function in COPD
NCT ID NCT07073950
First seen Jan 06, 2026 · Last updated May 15, 2026 · Updated 22 times
Summary
This study tests a triple-combination inhaler (Budesonide/Glycopyrronium/Formoterol) against a placebo in 56 adults with COPD and hyperinflation (overinflated lungs). The goal is to see if the inhaler improves both heart and lung function. Participants will be current or former smokers with moderate-to-severe COPD.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC OBSTRUCTIVE PULMONARY DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Research Site
NOT_YET_RECRUITINGAhrensburg, 22926, Germany
-
Research Site
RECRUITINGBerlin, 14050, Germany
-
Research Site
NOT_YET_RECRUITINGFrankfurt, 60596, Germany
-
Research Site
RECRUITINGHanover, 30625, Germany
-
Research Site
WITHDRAWNHarefield, UB9 6JH, United Kingdom
-
Research Site
RECRUITINGLondon, W1T 6AH, United Kingdom
-
Research Site
RECRUITINGManchester, M23 9QZ, United Kingdom
Conditions
Explore the condition pages connected to this study.